Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease

Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease ID - 451482 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451482/all/Ipratropium_bromide_versus_short_acting_beta_2_agonists_for_stable_chronic_obstructive_pulmonary_disease PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -